|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Financing expenses | |||||
| Financing income | |||||
| Total financing income, net | |||||
| Research and development expenses | |||||
| General and administrative expenses | |||||
| Operating loss | |||||
| Financing income (expenses), net | |||||
| Net loss and comprehensive loss | |||||
| Basic net loss per share (in Dollars per share) | |||||
| Diluted net loss per share (in Dollars per share) | |||||
| Weighted average number of ordinary shares used in computing basic net loss per share (in Shares) | |||||
| Weighted average number of ordinary shares used in computing diluted net loss per share (in Shares) |
Loading...
